Limei Zheng

H19 contributes to poor clinical features in NSCLC patients and leads to enhanced invasion in A549 cells through regulating miRNA-203-mediated epithelial-mesenchymal transition

Xiaojun Ge, Limei Zheng, Zhongxin Feng, 2018, Oncology letters.

Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990–2017: a population-based observational study

Xiaojun Ge, Limei Zheng, Junyao Jiang, 2020, BMJ Open.

Incidence and mortality of ovarian cancer at the global, regional, and national levels, 1990-2017.

Yong Li, Qi Wang, O. Shi, 2020, Gynecologic oncology.

MicroRNA expression profiles associated with acquired gefitinib-resistance in human lung adenocarcinoma cells.

F. Bi, Limei Zheng, Xiaojun Ge, 2015, Molecular medicine reports.

Mortality trends of liver cancer among patients with type 2 diabetes at the global and national level.

Xiaojun Ge, Limei Zheng, Junyao Jiang, 2020, Journal of diabetes and its complications.

Cetuximab enhances the efficiency of irinotecan through simultaneously inhibiting the MAPK signaling and ABCG2 in colorectal cancer cells.

Xiaojun Ge, Limei Zheng, Zhongxin Feng, 2019, Pathology, research and practice.